Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 11, Issue 2, pp. 475-484
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 20, 2011
- Revision received November 22, 2011
- Accepted November 22, 2011
- Published first December 5, 2011.
Article Versions
- Previous version (December 5, 2011 - 06:58).
- You are viewing the most recent version of this article.
Copyright & Usage
©2011 American Association for Cancer Research.
Author Information
- Weiwen Ying,
- Zhenjian Du,
- Lijun Sun,
- Kevin P. Foley,
- David A. Proia,
- Ronald K. Blackman,
- Dan Zhou,
- Takayo Inoue,
- Noriaki Tatsuta,
- Jim Sang,
- Shuxia Ye,
- Jamie Acquaviva,
- Luisa Shin Ogawa,
- Yumiko Wada,
- James Barsoum, and
- Keizo Koya
- Corresponding Author:
Weiwen Ying, Synta Pharmaceuticals Corp., 45 Hartwell Avenue, Lexington, MA 02421. Phone: 781-541-7243; Fax: 781-274-8228; E-mail: wying{at}syntapharma.com
February 2012
Volume 11, Issue 2
Volume 11, Issue 2
Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy
Jump to section
Advertisement